Active surveillance for recurrent low-grade non-muscle-invasive bladder cancer: Can we take any advantage from the COVID-19 crisis?

Detalles Bibliográficos
Autores principales: Hurle, Rodolfo, Maccagnano, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473177/
https://www.ncbi.nlm.nih.gov/pubmed/33029408
http://dx.doi.org/10.1080/2090598X.2020.1772031
_version_ 1783579133971791872
author Hurle, Rodolfo
Maccagnano, Carmen
author_facet Hurle, Rodolfo
Maccagnano, Carmen
author_sort Hurle, Rodolfo
collection PubMed
description
format Online
Article
Text
id pubmed-7473177
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-74731772020-10-06 Active surveillance for recurrent low-grade non-muscle-invasive bladder cancer: Can we take any advantage from the COVID-19 crisis? Hurle, Rodolfo Maccagnano, Carmen Arab J Urol Editorial Taylor & Francis 2020-06-14 /pmc/articles/PMC7473177/ /pubmed/33029408 http://dx.doi.org/10.1080/2090598X.2020.1772031 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Hurle, Rodolfo
Maccagnano, Carmen
Active surveillance for recurrent low-grade non-muscle-invasive bladder cancer: Can we take any advantage from the COVID-19 crisis?
title Active surveillance for recurrent low-grade non-muscle-invasive bladder cancer: Can we take any advantage from the COVID-19 crisis?
title_full Active surveillance for recurrent low-grade non-muscle-invasive bladder cancer: Can we take any advantage from the COVID-19 crisis?
title_fullStr Active surveillance for recurrent low-grade non-muscle-invasive bladder cancer: Can we take any advantage from the COVID-19 crisis?
title_full_unstemmed Active surveillance for recurrent low-grade non-muscle-invasive bladder cancer: Can we take any advantage from the COVID-19 crisis?
title_short Active surveillance for recurrent low-grade non-muscle-invasive bladder cancer: Can we take any advantage from the COVID-19 crisis?
title_sort active surveillance for recurrent low-grade non-muscle-invasive bladder cancer: can we take any advantage from the covid-19 crisis?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473177/
https://www.ncbi.nlm.nih.gov/pubmed/33029408
http://dx.doi.org/10.1080/2090598X.2020.1772031
work_keys_str_mv AT hurlerodolfo activesurveillanceforrecurrentlowgradenonmuscleinvasivebladdercancercanwetakeanyadvantagefromthecovid19crisis
AT maccagnanocarmen activesurveillanceforrecurrentlowgradenonmuscleinvasivebladdercancercanwetakeanyadvantagefromthecovid19crisis

Ejemplares similares